Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS

(MedPage Today) -- Patients with lower-risk myelodysplastic syndromes (MDS) who relapsed or were refractory to standard treatment achieved improved rates of red blood cell (RBC) transfusion independence with an investigational, first-in-class telomerase...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news